Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients.
Archives of toxicology 2014 Apr 88 (4): 901-11.
Lin Victor C, Huang Chao-Yuan, Lee Yung-Chin, Yu Chia-Cheng, Chang Ta-Yuan, Lu Te-Ling, Huang Shu-Pin, Bao Bo-Yi
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: